Enapotamab (1912423-61-0): A Research Reagent Overview
Enapotamab, also designated as, known as 1912423-61-0, is a, the research, laboratory reagent, compound, substance gaining attention, prominence, interest within the, scientific community, field for its potential, possible, anticipated utility, application, role in biomedical, immunological, therapeutic investigations. This, It highly specific, selective antibody, protein, molecule targets, binds to, interacts with a, the particular, defined target, antigen, molecule involved, implicated, associated in disease, pathology, immune response processes, mechanisms. Currently, As of now, it, this reagent is primarily, exclusively available, offered for academic, non-commercial research, experimental purposes, applications and is not, isn't approved, sanctioned for clinical, diagnostic use, implementation. Further, Additional studies, investigations are necessary, required to fully, completely elucidate, determine its capabilities, functionality, scope and validate, confirm its value, utility as a, the viable, promising therapeutic, diagnostic tool, agent.
```
```text
Enapotamab: Facilitating Innovative Research Uses
Enapotamab, a emerging medicinal agent, is rapidly opening avenues for exciting study applications. Its potential to selectively bind defined tissue kinds provides scientists with a versatile resource to examine sophisticated cellular mechanisms. This allows exceptional clarifications into condition development and facilitates the creation of novel diagnostic and therapeutic approaches. Furthermore, scientists can now utilize enapotamab to investigate formerly inaccessible biological locations, paving the course for transformative revelations.
```
High-Purity Enapota Specifications and Access
Research-grade enapotamab, previously known as Compound X, is available through a limited number of select suppliers, primarily catering to institutional research laboratories. Existing specifications typically include a specified purity of ≥98%, as determined by liquid chromatography, with rigorous control over related impurities. The compound weight is around 150 kDa, with a usual formulation consisting of a lyophilized powder to be reconstituted a suitable buffer. Between batches consistency is assured through detailed quality assurance procedures and comprehensive documentation .
- Purity : ≥98%
- Mass : ~150 kDa
- State : Lyophilized Powder
```
Enapotamab Reagent (1912423-61-0) for Biological Studies
The Enapotama reagent, identified by the CAS number 1912423-61-0, is increasingly employed in a range of biological studies. This new antibody-based compound facilitates the exploration of defined cellular activities, often associated to cellular response and specific protein interactions. Researchers are evaluating its potential in elucidating disease etiology and creating medicinal strategies. Further research are needed to fully define its characteristics and enhance its use in various biological contexts.
```
Utilizing Enapotamab regarding Leading-Edge Investigation
Scientists are actively focusing interest on enapotamab, a unique agent, in utilizing website its potential within groundbreaking investigation. This work presents the opportunity for deepen our understanding of intricate immunological processes and perhaps reveal new medical methods regarding several conditions. Additional analysis into enapotamab's mechanism of effect indicates a significant influence on the future of health study.
Enapotamab (1912423-61-0): A Supply for High-Quality Compound Data
Seeking dependable access to this chemical (1912423-61-0)? We provide the excellent chemical solution created for research applications. Our substance is manufactured with strict assurance protocols, verifying peak results in various analyses. We understand the essential part that premium compounds play in academic pursuits.
- Purity guaranteed to specified levels.
- Detailed documents of analysis provided.
- Safe containment for product stability.
Contact our team for learn more about the substance chemical and it can benefit your projects.